Top Eminent Healthcare Tightens Audit Committee Rules to Meet New Governance Code

The latest announcement is out from CLSA Premium Ltd. ( (HK:6877) ).

Top Eminent Healthcare Group Limited has updated the terms of reference for its audit committee, reflecting a series of board resolutions dating back to 2012 and most recently incorporating the 2025 Corporate Governance Code enhancements. The revised framework strengthens risk oversight, internal control disclosures and auditor independence, setting clearer requirements for committee composition, meeting frequency and procedures, and reinforcing governance safeguards such as restrictions on former audit firm partners and the need for qualified independent directors.

The audit committee must now consist of at least three non-executive directors, with a majority being independent and at least one possessing appropriate accounting or financial management expertise. Meetings are mandated at least twice a year and may be convened by the committee chair, any committee member or the external auditors, while quorum, notice periods, and secretarial arrangements are clearly defined to support more robust and transparent oversight of the company’s financial reporting and control environment.

The most recent analyst rating on (HK:6877) stock is a Hold with a HK$0.15 price target. To see the full list of analyst forecasts on CLSA Premium Ltd. stock, see the HK:6877 Stock Forecast page.

More about CLSA Premium Ltd.

Top Eminent Healthcare Group Limited is a Cayman Islands-incorporated company listed in Hong Kong under stock code 6877. The group operates in the healthcare sector, overseen by a board of directors that includes non-executive and independent non-executive directors subject to Hong Kong Listing Rules and corporate governance standards.

Average Trading Volume: 943,061

Technical Sentiment Signal: Sell

Current Market Cap: HK$335.5M

For detailed information about 6877 stock, go to TipRanks’ Stock Analysis page.